Literature DB >> 65563

Previous pregnancy as a protective factor against death from melanoma.

P Hersey, G Morgan, D E Stone, W H McCarthy, G W Milton.   

Abstract

Examination of the case-records of women presenting to the Melanoma Unit at Sydney Hospital over the period 1961-71 has shown that women with pregnancies before the development of melanoma had a better survival-rate from melanoma than women without previous pregnancies. The known presence of fetal antigens on melanoma cells and immunisation against fetal antigens during pregnancy suggest an immunological explanation for these results. Exposure to fetal antigens during pregnancy may protect against the dissemination of melanoma cells bearing similar fetal antigens and thus increase the survival-rate. The incidence of melanoma in males and females was approximately equal, which suggests that immune responses to tumour-associated antigens may be more effective in preventing spread of tumours than in preventing their occurrence.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 65563     DOI: 10.1016/s0140-6736(77)91943-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  12 in total

1.  Malignant melanoma and pregnancy ten questions.

Authors:  R O Dillman; L A Vandermolen; N M Barth; K J Bransford
Journal:  West J Med       Date:  1996-02

2.  Natural history of cutaneous malignant melanoma.

Authors:  H A Briele; T K Das Gupta
Journal:  World J Surg       Date:  1979-07-30       Impact factor: 3.352

3.  Malignant melanoma: an evolutionary theory to explain its behaviour.

Authors:  G W Milton
Journal:  Ann R Coll Surg Engl       Date:  1978-01       Impact factor: 1.891

4.  Expression by human fetal organs of organ-specific cancer neoantigens as measured by leukocyte adherence inhibition.

Authors:  M Gubersky; D M Thomson; M Lajzerowicz
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

5.  Reaction of the leukocytes of melanoma patients and control donors, including pregnant women, with melanoma- and fetus-derived materials.

Authors:  A J Cochran; G Todd; D M Hart; L J Morrison; R M MacKie
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

6.  Uveal melanomas presenting during pregnancy and the investigation of oestrogen receptors in melanomas.

Authors:  J M Seddon; D T MacLaughlin; D M Albert; E S Gragoudas; M Ference
Journal:  Br J Ophthalmol       Date:  1982-11       Impact factor: 4.638

7.  Relationship of natural killer-cell activity to rhesus antigens in man.

Authors:  P Hersey; A Edwards; C Trilivas; H Shaw; G W Milton
Journal:  Br J Cancer       Date:  1979-03       Impact factor: 7.640

8.  Reproductive factors, oral contraceptives and risk of malignant melanoma: Western Canada Melanoma Study.

Authors:  R P Gallagher; J M Elwood; G B Hill; A J Coldman; W J Threlfall; J J Spinelli
Journal:  Br J Cancer       Date:  1985-12       Impact factor: 7.640

9.  Malignant melanoma and oral contraceptive use among women in California.

Authors:  V Beral; S Ramcharan; R Faris
Journal:  Br J Cancer       Date:  1977-12       Impact factor: 7.640

10.  Malignant melanoma: sex differences in survival after evidence of distant metastasis.

Authors:  F Rampen
Journal:  Br J Cancer       Date:  1980-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.